Jane Street’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $53.3M | Buy |
938,699
+636,419
| +211% | +$28.2M | ﹤0.01% | 1371 |
|
|
2026
Q1 | $8.98M | Sell |
302,280
-89,993
| -23% | -$2.69M | ﹤0.01% | 2670 |
|
|
2025
Q4 | $15M | Buy |
+392,273
| New | +$12.8M | ﹤0.01% | 1870 |
|
|
2025
Q2 | – | Sell |
-72,018
| Closed | -$1.19M | – | 10929 |
|
|
2025
Q1 | $1.29M | Buy |
72,018
+6,328
| +10% | +$128K | ﹤0.01% | 5097 |
|
|
2024
Q4 | $1.14M | Sell |
65,690
-245,570
| -79% | -$4.34M | ﹤0.01% | 5115 |
|
|
2024
Q3 | $4.35M | Sell |
311,260
-98,597
| -24% | -$1.03M | ﹤0.01% | 3083 |
|
|
2024
Q2 | $3.37M | Buy |
409,857
+20,649
| +5% | +$139K | ﹤0.01% | 3617 |
|
|
2024
Q1 | $3M | Buy |
389,208
+137,108
| +54% | +$1.16M | ﹤0.01% | 3406 |
|
|
2023
Q4 | $2.27M | Buy |
252,100
+84,554
| +50% | +$616K | ﹤0.01% | 4105 |
|
|
2023
Q3 | $1.5M | Buy |
167,546
+99,560
| +146% | +$1.4M | ﹤0.01% | 4525 |
|
|
2023
Q2 | $1.04M | Sell |
67,986
-173,258
| -72% | -$3.15M | ﹤0.01% | 5123 |
|
|
2023
Q1 | $5.43M | Buy |
+241,244
| New | +$5.13M | ﹤0.01% | 2335 |
|
|
2022
Q3 | – | Sell |
-27,994
| Closed | -$678K | – | 10492 |
|
|
2022
Q2 | $678K | Buy |
+27,994
| New | +$704K | ﹤0.01% | 6181 |
|
|
2022
Q1 | – | Sell |
-10,104
| Closed | -$268K | – | 11037 |
|
|
2021
Q4 | $314K | Sell |
10,104
-314
| -3% | -$8.84K | ﹤0.01% | 8085 |
|
|
2021
Q3 | $253K | Sell |
10,418
-58,526
| -85% | -$1.08M | ﹤0.01% | 8490 |
|
|
2021
Q2 | $1.01M | Buy |
68,944
+59,335
| +617% | +$1.17M | ﹤0.01% | 5836 |
|
|
2021
Q1 | $240K | Sell |
9,609
-9,568
| -50% | -$264K | ﹤0.01% | 8022 |
|
|
2020
Q4 | $523K | Buy |
19,177
+1,532
| +9% | +$35.8K | ﹤0.01% | 5672 |
|
|
2020
Q3 | $326K | Buy |
+17,645
| New | +$343K | ﹤0.01% | 5763 |
|
|
2019
Q4 | – | Sell |
-21,016
| Closed | -$244K | – | 5766 |
|
|
2019
Q3 | $244K | Buy |
+21,016
| New | +$347K | ﹤0.01% | 4408 |
|
|
2018
Q4 | – | Sell |
-79,920
| Closed | -$2.3M | – | 5735 |
|
|
2018
Q3 | $2.3M | Buy |
+79,920
| New | +$2.28M | ﹤0.01% | 1761 |
|
|
2016
Q2 | – | Sell |
-13,381
| Closed | -$183K | – | 4616 |
|
|
2016
Q1 | $183K | Buy |
+13,381
| New | +$203K | ﹤0.01% | 3741 |
|
|
2015
Q3 | – | Sell |
-17,986
| Closed | -$596K | – | 4159 |
|
|
2015
Q2 | $596K | Buy |
17,986
+6,421
| +56% | +$176K | ﹤0.01% | 2106 |
|
|
2015
Q1 | $277K | Buy |
+11,565
| New | +$176K | ﹤0.01% | 2585 |
|
|
2014
Q4 | – | Sell |
-10,280
| Closed | -$93K | – | 3044 |
|
|
2014
Q3 | $93K | Buy |
+10,280
| New | +$121K | ﹤0.01% | 2366 |
|
|
2014
Q2 | – | Sell |
-119,356
| Closed | -$2.53M | – | 3134 |
|
|
2014
Q1 | $2.53M | Buy |
+119,356
| New | +$1.84M | 0.03% | 464 |
|
Other funds holding TVTX
JT
NAMI
RSCM
SIMG
Jane Street's TVTX Position: Q2 2026 in Review
Jane Street increased its Travere Therapeutics (TVTX) stake by 211% in Q2 2026, buying an estimated $28.2M and bringing the position to 938,699 shares worth $53.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1371.
Jane Street first reported a position in TVTX in Q1 2014 and has held it in 26 quarters since. 291 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.
- Jane Street held 938,699 shares of Travere Therapeutics worth $53.3M as of Q2 2026.
- Jane Street bought 636,419 Travere Therapeutics shares in Q2 2026, an estimated $28.2M.
- Travere Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #1371 holding.
- Jane Street first reported a position in Travere Therapeutics in Q1 2014 and has held it in 26 quarters since.
- 291 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.